What is Candel Therapeutics, Inc.'s capex?

Candel Therapeutics, Inc. (CADL) reported capex of $675K in Q1 2026.

How has Candel Therapeutics, Inc.'s capex changed year-over-year?

Candel Therapeutics, Inc.'s capex increased by 22400.0% year-over-year, from $3K to $675K.

What is the long-term trend for Candel Therapeutics, Inc.'s capex?

Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s capex has grown at a -24.8% compound annual growth rate (CAGR), from $1.84M to $587K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Candel Therapeutics, Inc. CADL CapEx

CapEx at other companies

Bristol-Myers SquibbBMY

$347M+33.5%

AmgenAMGN

$712M+73.2%

Gilead SciencesGILD

$117M+12.5%

Replimune GroupREPL

$135K-92.5%

CG OncologyCGON

$304K+1,800%

Immix Biopharma, Inc.IMMX

$32.49K-52.0%

Other financials

Income statement

See full

Revenue$31.0K0.0%

Operating income-$16.3M-100%

Net income-$8.9M-220%

EPS (diluted)-$0.14-208%

Balance sheet

See full

Cash & equivalents$194.8M+111%

Total debt$2.8M-73.9%

Total equity$138.0M+84.8%

Total assets$201.9M+111%

Cash flow

See full

Operating cash flow-$18.0M-109%

Free cash flow-$18.7M-117%

Valuation

See full

Market cap$693.87M+192%

Enterprise value$501.88M+220%

P/S5,595.7×-18,674×

Profitability

See full

Operating margin-28,000.8%+15,050pp

Net margin-15,156.5%-5,064pp

FCF margin-26,383.9%+14,851pp

Returns & leverage

See full

Return on equity-51.2%-16.6pp

Debt / equity0×-0.1×

Current ratio28×+23.4×

Where this comes from

Reported directly by Candel Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Candel Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Candel Therapeutics, Inc.'s capex?: Candel Therapeutics, Inc. (CADL) reported capex of $675K in Q1 2026.
How has Candel Therapeutics, Inc.'s capex changed year-over-year?: Candel Therapeutics, Inc.'s capex increased by 22400.0% year-over-year, from $3K to $675K.
What is the long-term trend for Candel Therapeutics, Inc.'s capex?: Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s capex has grown at a -24.8% compound annual growth rate (CAGR), from $1.84M to $587K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.